David Issadore
Editors

2013

Over the last several decades, our ability to understand and diagnose disease has dramatically progressed due to advances in quantitative measurements of molecular biomarkers. Techniques such as genetic sequencing, mass spectrometry, flow cytometry, and nuclear magnetic resonance have enabled sophisticated and highly sensitive measurements of biological material that promise improvements in early diagnosis, accurate monitoring of existing diseases, and understanding of the underlying causes and mechanisms of disease.